1887

Abstract

Summary

A study of 1314 patients with malignancies was made to determine the prevalence in surveillance, diagnostic, and environmental cultures. Sera obtained from a commercial source were used to determine serotypic distributions of the strains isolated during a 51-month period. was isolated from 19% of patients with haematological neoplasms, from 5% of patients with lymphoma, and from 6% of those with solid tumours. Among carriers, rectal cultures were the commonest source in patients with lymphoma (32%); rectal and gingival cultures in patients with leukaemia (43% and 39%, respectively), and gingival cultures in patients with solid tumours (30%). Bacteraemias (07%) were infrequent sources. Although seldom isolated from environmental or food samples, may occasionally be abundant in fresh fruit and vegetables. Serotyping of 220 strains of demonstrated 38 distinct antigenic types. The predominant serotype, 014: H12, was present in the upper respiratory tract of half of the persons who carried this serotype. Serotyping is a readily reproducible method of subspeciating it can be satisfactorily used as an epidemiological tool.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-13-2-333
1980-05-01
2022-01-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/13/2/medmicro-13-2-333.html?itemId=/content/journal/jmm/10.1099/00222615-13-2-333&mimeType=html&fmt=ahah

References

  1. Allen S. D., Conger K. B. 1969; Serratia marcescens infection of the urinary tract: a nosocomial infection. J. Urol 101:621
    [Google Scholar]
  2. Anderhub B., Pitt T. L., Erdman Y. J., Willcox W. R. 1977; A comparison of typing methods for serratia marcescens. J. Hyg., camb 79:89
    [Google Scholar]
  3. Davis J. T., Foltz E., Blakemore W. S. 1970; Serratia marcescens. A pathogen of increasing clinical importance. J. Am. Med., ass 214:2190
    [Google Scholar]
  4. Edwards P. R., Ewing W. H. 1972; Identification of enterobacteriaceae. 3rd ed Burgess pub. Co.; minneapolis:
    [Google Scholar]
  5. Ewing W. H., Martin W. J. 1974; Enterobacteriaceae. In Manual of clinical microbiology 2nd ed edited by Lennette E. H. Spaulding E. H., Trauant J. P. Am. Soc. For microbiol.; Washington DC: p 189
    [Google Scholar]
  6. Farmer J. J. III 1972; Epidemiological differentiation of serratia marcescens: typing by bacteriocin sensitivity. Appl. Microbiol 23:226
    [Google Scholar]
  7. Griffiths E. K., Surgalla M. J., Fitzpatrick J. E., Neter E. 1977; Antibody response to serratia marcescens isolated from patients with malignant diseases. J. Clin. Microbiol 6:499
    [Google Scholar]
  8. Le Minor S., Pigache F. 1977; Etude antigenique de souches de serratia marcescens isolees en france. I. Antigenes h: individualisation de six nouveaux facteurs h. Annls microbiol. (inst. Pasteur) 128b:207
    [Google Scholar]
  9. Le Minor S., Pigache F. 1978; II. Caracterisation des antigenes o et individualisation de 5 nouveaux facteurs, frequence des serotypes et designation de nouveaux facteurs h. Annls microbiol. (inst. Pasteur) 129b:407
    [Google Scholar]
  10. Maki D. G., Hennekens C. G., Phillips C. W., Shaw W. V., Bennett J.V. 1973; Nosocomial urinary tract infection with serratia marcescens: an epidemiologic study. J. Infect. Dis 128:579
    [Google Scholar]
  11. Negut M., Davis B. R., Washington J. A. II 1975; Biochemical and serological characteristics of serratia marcescens isolated from various clinical and environmental sources. Archs roum. Path. Exp. Microbiol 34: (nos. 1-2) p 33
    [Google Scholar]
  12. Ostensen R. C., Fields B. T., Nolan C. M. 1977; Polymyxin b and rifampin: new regimen for multiresistant serratia marcescens infections. Antimicrob. Ag. Chemother 12:655
    [Google Scholar]
  13. Pillich J., Hradecna Z., Kocur M. 1964; An attempt at phage typing in genus serratia. J. Appl. Bact 27:65
    [Google Scholar]
  14. Prinsloo H. E. 1966; Bacteriocins and phages produced by serratia marcescens. J. Gen. Microbiol 45:205
    [Google Scholar]
  15. Roemisch E., Kocka F. E. 1976; Comparison of methods for differentiating among serratia marcescens isolated from clinical specimens. Am. J. Clin. Path 66:96
    [Google Scholar]
  16. Rubin S. J., Brock S., Chamberland M., Lyons R. W. 1976; Combined serotyping and biotyping of serratia marcescens. J. Clin. Microbiol 3:582
    [Google Scholar]
  17. Sanders C. V., Luby J. P. Jr, Johanson W. G. Jr, Barnett J. A., Sanford J. P. 1970; Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann. Intern. Med 73:15
    [Google Scholar]
  18. Schaberg D. R., Alford R. H., Anderson R., Farmer J. J. III, Melly M. A., Schaffner W. 1976; An outbreak of nosocomial infections due to multiply resistant serratia marcescens: evidence of inter-hospital spread. J. Infect. Dis 134:181
    [Google Scholar]
  19. Traub W. H. 1972; Continued surveillance of serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit. Appl. Microbiol 23:982
    [Google Scholar]
  20. Traub W. H., Kleber I;. 1977; Serotyping of serratia marcescens: evaluation of le minors h-immobilization test and description of three new flagellar h antigens. J. Clin. Microbiol 5:115
    [Google Scholar]
  21. Traub W. H., Kleber I., Puhler A., Burkardt H. J. 1976; Characterization of a nosocomially significant, multiple drug-resistant strain of serratia marcescens. Chemotherapy 22:297
    [Google Scholar]
  22. Traub W. H., Raymond E. A. 1971; Epidemiological surveillance of serratia marcescens infections by bacteriocin typing. Appl. Microbiol 22:1058
    [Google Scholar]
  23. Wilfert J. N., Barrett F. F., Ewing W. H., Finland M., Kass E. H. 1970; Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at boston city hospital. Appl. Microbiol 19:345
    [Google Scholar]
  24. Wilkowske C. J., Washington J. A. II, Martin W. J., Ritts R. E. 1970; Serratia marcescens: biochemical characteristics, antibiotic susceptibility patterns, and clinical significance. J. Am. Med. Ass 214:2157
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-13-2-333
Loading
/content/journal/jmm/10.1099/00222615-13-2-333
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error